Cargando…
Lipidomics Reveals Cisplatin-Induced Renal Lipid Alterations during Acute Kidney Injury and Their Attenuation by Cilastatin
Nephrotoxicity is a major complication of cisplatin-based chemotherapy, leading to acute kidney injury in ca. 30% of patients, with no preventive intervention or treatment available for clinical use. Cilastatin has proved to exert a nephroprotective effect for cisplatin therapies in in vitro and in...
Autores principales: | Moreno-Gordaliza, Estefanía, Marazuela, Maria Dolores, Pastor, Óscar, Lázaro, Alberto, Gómez-Gómez, María Milagros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622622/ https://www.ncbi.nlm.nih.gov/pubmed/34830406 http://dx.doi.org/10.3390/ijms222212521 |
Ejemplares similares
-
Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy
por: Zaballos, Matilde, et al.
Publicado: (2021) -
Nephroprotective Effect of Cilastatin against Gentamicin-Induced Renal Injury In Vitro and In Vivo without Altering Its Bactericidal Efficiency
por: Jado, Juan Carlos, et al.
Publicado: (2020) -
FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats
por: González-Fernández, Rebeca, et al.
Publicado: (2022) -
Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity
por: Humanes, Blanca, et al.
Publicado: (2015) -
New evidence in severe pneumonia: imipenem/ cilastatin/relebactam
por: Girón, Rosa Mª, et al.
Publicado: (2022)